Tom Biegala and Ben Hemani, co-founders of Bison Ventures, dive into the nitty-gritty of scaling frontier tech. They discuss why AI isn't a miracle solution for biotech, yet remains vital for drug discovery. The duo also highlights eye-catching robotics startups, the tricky path to finding product-market fit, and the differences between pursuing venture funding versus grants. Their insights reveal both the excitement and the real challenges facing innovators in material science, climate, and more.
